Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,802,000 | 9,053,000 | 4,727,000 | 13,831,000 | 10,312,000 |
| Depreciation Amortization | 2,904,000 | 1,965,000 | 1,013,000 | 4,104,000 | 3,002,000 |
| Income taxes - deferred | 297,000 | 593,000 | 495,000 | -607,000 | -224,000 |
| Accounts receivable | -453,000 | -621,000 | -451,000 | -763,000 | -1,003,000 |
| Other Working Capital | -1,555,000 | -2,502,000 | -2,547,000 | -959,000 | -319,000 |
| Other Operating Activity | -889,000 | 964,000 | 686,000 | 1,808,000 | 1,507,000 |
| Operating Cash Flow | $14,106,000 | $9,452,000 | $3,923,000 | $17,414,000 | $13,275,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2,263,000 | -894,000 | -595,000 | -3,137,000 | -1,974,000 |
| Net Acquisitions | -291,000 | N/A | N/A | -835,000 | -819,000 |
| Purchase Of Investment | -25,784,000 | -17,352,000 | -5,427,000 | -18,923,000 | -13,583,000 |
| Sale Of Investment | 14,576,000 | 8,222,000 | 4,077,000 | 18,058,000 | 12,891,000 |
| Other Investing Activity | -147,000 | -94,000 | -81,000 | -266,000 | -40,000 |
| Investing Cash Flow | $-9,383,000 | $-10,118,000 | $-2,026,000 | $-5,103,000 | $-3,525,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 629,000 | 1,668,000 | 278,000 | 1,411,000 | 1,770,000 |
| Debt Issued | 17,000 | 13,000 | 16,000 | 3,607,000 | 51,000 |
| Debt Repayment | -1,787,000 | -1,777,000 | -21,000 | -1,593,000 | -1,531,000 |
| Common Stock Issued | 1,406,000 | 1,048,000 | 586,000 | 2,649,000 | 2,271,000 |
| Common Stock Repurchased | -4,381,000 | -1,966,000 | -774,000 | -3,538,000 | -3,050,000 |
| Dividend Paid | -5,812,000 | -3,845,000 | -1,867,000 | -7,286,000 | -5,424,000 |
| Other Financing Activity | -1,713,000 | -1,066,000 | -1,275,000 | -1,341,000 | -1,360,000 |
| Financing Cash Flow | $-11,641,000 | $-5,925,000 | $-3,057,000 | $-6,091,000 | $-7,273,000 |
| Exchange Rate Effect | -191,000 | -100,000 | -45,000 | -204,000 | -184,000 |
| Beginning Cash Position | 20,927,000 | 20,927,000 | 20,927,000 | 14,911,000 | 14,911,000 |
| End Cash Position | 13,818,000 | 14,236,000 | 19,722,000 | 20,927,000 | 17,204,000 |
| Net Cash Flow | $-7,109,000 | $-6,691,000 | $-1,205,000 | $6,016,000 | $2,293,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,106,000 | 9,452,000 | 3,923,000 | 17,414,000 | 13,275,000 |
| Capital Expenditure | -2,218,000 | -1,467,000 | -630,000 | -3,595,000 | -2,166,000 |
| Free Cash Flow | 11,888,000 | 7,985,000 | 3,293,000 | 13,819,000 | 11,109,000 |